CellCura ASA (FRA:C6L) Debt-to-Equity : -1.22 (As of Jun. 2014)

CellCura ASA Debt-to-Equity Chart

CellCura ASA Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Debt-to-Equity	Get a 7-Day Free Trial															-1.82	-3.56	-1.59	-1.57	-1.22

Competitive Comparison of CellCura ASA's Debt-to-Equity

For the Biotechnology subindustry, CellCura ASA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CellCura ASA's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CellCura ASA's Debt-to-Equity falls into.

CellCura ASA Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CellCura ASA's Debt to Equity Ratio for the fiscal year that ended in Dec. 2013 is calculated as

CellCura ASA's Debt to Equity Ratio for the quarter that ended in Jun. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellCura ASA  (FRA:C6L) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

CellCura ASA Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CellCura ASA (FRA:C6L) Business Description